(1)These Regulations may be cited as the Medicines (Advertising) Amendment Regulations 1996 and shall come into force on 12th July 1996.
(2)In these Regulations “the principal Regulations” means the Medicines (Advertising) Regulations 1994.
2Amendment of regulation 6 of and Schedule 1 to the principal Regulations#
(1)For regulation 6 paragraph (2) of the principal Regulations (prohibition of advertisements referring to specified diseases), there shall be substituted the following paragraph—“2 Paragraph (1) shall not be taken to prohibit a person from issuing an advertisement which is likely to lead to the use of a relevant medicinal product—a for the purpose of the prevention of neural tube defects; orb for the purpose of the treatment ofi the symptoms of sprains or strains, orii the pain or stiffness of rheumatic or non-serious arthritic conditions.”
(2)In Schedule 1 to the principal Regulations (diseases in respect of which advertisements to the public are prohibited), after the entry “Genetic disorders” there shall be inserted the entry “Joint, rheumatic and collagen diseases”.
Contains public sector information licensed under the Open Government Licence v3.0.